Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Southern Petrochemical Industries Corporation (SPIC) is a prominent Indian conglomerate that operates a significant pharmaceutical and biotechnology division alongside its core fertilizer business. The company's pharmaceutical arm is a major manufacturer of Active Pharmaceutical Ingredients (APIs), specializing in fermentation-based products such as Penicillin-G, 6-APA, and 7-ADCA. SPIC was notably one of the first companies in India to establish a large-scale fermentation plant for antibiotic production. Its biotechnology division focuses on agricultural applications, including bio-fertilizers and tissue culture, while its healthcare unit provides medical devices and diagnostic services. The company serves both domestic and international markets as a key supplier in the antibiotic value chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPIC.